Delivering a pre-systemic anticancer therapy patient education session
Cancer Nursing Practice · 06.01.2025 · 24 (1) · 33-41
DOI: 10.7748/cnp.2024.e1875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Nursing Practice, online erschienen am 30.09.2024. Verfasst von Sam Gayle. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Systemic anticancer therapy (SACT) incorporates all types of therapies used to treat cancer, including cytotoxic therapy (also called chemotherapy), immunotherapy, hormonal therapies and targeted therapies. Nurse-led pre-SACT patient education sessions aim to inform patients about their treatment, including its potential side effects and what they should do if they experience symptoms, to enhance patient safety and to reinforce informed consent. This article discusses the importance of pre-SACT patient education sessions in the context of cytotoxic therapy and details six areas for nurses to consider when planning on delivering such sessions.
Zitieren
APA
Gayle, S. (2025). Delivering a pre-systemic anticancer therapy patient education session. Cancer Nursing Practice, 24(1), 33-41. https://doi.org/10.7748/cnp.2024.e1875
Vancouver
Gayle S. Delivering a pre-systemic anticancer therapy patient education session. Cancer Nursing Practice. 2025;24(1):33-41. doi:10.7748/cnp.2024.e1875
BibTeX
@article{Gayle2025,
author = {Gayle, Sam},
title = {Delivering a pre-systemic anticancer therapy patient education session},
journal = {Cancer Nursing Practice},
year = {2025},
volume = {24},
number = {1},
pages = {33--41},
doi = {10.7748/cnp.2024.e1875}
}
EUVIMED